Burning Rock Biotech (BNR) Competitors $8.36 -0.22 (-2.56%) Closing price 03:59 PM EasternExtended Trading$8.30 -0.05 (-0.66%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNR vs. TOI, LFMD, VMD, XGN, DCGO, SERA, QIPT, CORBF, EUDA, and PIIIShould you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include Oncology Institute (TOI), LifeMD (LFMD), Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Global Cord Blood (CORBF), EUDA Health (EUDA), and P3 Health Partners (PIII). These companies are all part of the "healthcare" industry. Burning Rock Biotech vs. Its Competitors Oncology Institute LifeMD Viemed Healthcare Exagen DocGo Sera Prognostics Quipt Home Medical Global Cord Blood EUDA Health P3 Health Partners Burning Rock Biotech (NASDAQ:BNR) and Oncology Institute (NASDAQ:TOI) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, profitability, earnings and analyst recommendations. Do analysts rate BNR or TOI? Oncology Institute has a consensus price target of $7.00, suggesting a potential upside of 84.70%. Given Oncology Institute's stronger consensus rating and higher probable upside, analysts plainly believe Oncology Institute is more favorable than Burning Rock Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Oncology Institute 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.75 Which has more volatility & risk, BNR or TOI? Burning Rock Biotech has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, Oncology Institute has a beta of 0.08, meaning that its stock price is 92% less volatile than the S&P 500. Which has higher valuation and earnings, BNR or TOI? Burning Rock Biotech has higher revenue and earnings than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBurning Rock Biotech$536.30M0.17-$47.49M-$1.90-4.40Oncology Institute$393.41M0.90-$64.66M-$0.68-5.57 Is BNR or TOI more profitable? Oncology Institute has a net margin of -14.26% compared to Burning Rock Biotech's net margin of -26.04%. Burning Rock Biotech's return on equity of -23.61% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Burning Rock Biotech-26.04% -23.61% -15.73% Oncology Institute -14.26%-1,527.21%-34.25% Does the media refer more to BNR or TOI? In the previous week, Burning Rock Biotech and Burning Rock Biotech both had 3 articles in the media. Burning Rock Biotech's average media sentiment score of 0.83 equaled Oncology Institute'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Burning Rock Biotech 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Oncology Institute 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of BNR or TOI? 30.0% of Burning Rock Biotech shares are owned by institutional investors. Comparatively, 36.9% of Oncology Institute shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by company insiders. Comparatively, 8.5% of Oncology Institute shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryOncology Institute beats Burning Rock Biotech on 8 of the 15 factors compared between the two stocks. Get Burning Rock Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNR vs. The Competition Export to ExcelMetricBurning Rock BiotechTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$89.96M$222.48T$94.72T$10.26BDividend YieldN/A1.64%2.85%4.69%P/E Ratio-4.4024.0125.9426.60Price / Sales0.17165,693.2974,762.31178.23Price / CashN/A55.9731.0862.20Price / Book1.13420,318.62185,976.796.54Net Income-$47.49M$27.08M$196.66M$275.87M7 Day Performance-8.53%9,672,932.61%3,926,812.79%-1.32%1 Month Performance-5.75%9,672,942.72%3,941,497.67%5.24%1 Year Performance155.66%19,757,262.93%7,791,627.70%31.56% Burning Rock Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNRBurning Rock Biotech0.8235 of 5 stars$8.36-2.6%N/A+152.4%$89.96M$536.30M-4.401,390News CoverageAnalyst ForecastTOIOncology Institute2.2179 of 5 stars$3.81+4.7%$7.00+83.7%+1,113.9%$340.36M$393.41M-5.60660Analyst ForecastLFMDLifeMD3.4392 of 5 stars$6.94-0.4%$13.17+89.7%+46.7%$330.50M$212.45M-33.05230Trending NewsAnalyst ForecastVMDViemed Healthcare2.2314 of 5 stars$6.87-0.9%N/A-19.2%$268.79M$224.26M20.211,179XGNExagen4.0542 of 5 stars$10.90-0.5%$12.00+10.1%+307.4%$241.16M$55.64M-12.25220Analyst ForecastDCGODocGo1.912 of 5 stars$1.24-2.4%$3.24+161.1%-62.5%$124.22M$616.55M-6.534,407News CoverageAnalyst DowngradeHigh Trading VolumeSERASera Prognostics1.2306 of 5 stars$3.26+0.3%N/A-50.2%$122.44M$80K-3.84120Analyst ForecastQIPTQuipt Home Medical2.8788 of 5 stars$2.57-1.5%$3.15+22.6%-6.7%$113.39M$245.91M-10.711,200Analyst ForecastCORBFGlobal Cord BloodN/A$0.75-25.0%N/AN/A$91.16M$196.12M0.001,200Gap DownEUDAEUDA Health1.2369 of 5 stars$2.36+5.8%N/A-27.5%$82.86M$4.01M0.002PIIIP3 Health Partners2.8127 of 5 stars$8.91+3.0%$16.25+82.4%-43.7%$62.17M$1.50B-0.19500News CoverageAnalyst Forecast Related Companies and Tools Related Companies Oncology Institute Competitors LifeMD Competitors Viemed Healthcare Competitors Exagen Competitors DocGo Competitors Sera Prognostics Competitors Quipt Home Medical Competitors Global Cord Blood Competitors EUDA Health Competitors P3 Health Partners Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BNR) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredBig Oil Firm Stakes $1 Billion in Startup That Could Kill Big OilOn September 22, the unthinkable happened... One of the world's biggest oil producers poured $1 billion int...Stansberry Research | SponsoredToo busy for AI trading?Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Burning Rock Biotech Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Burning Rock Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
